Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
11.2M
-
Shares change
-
+1.42M
-
Total reported value, excl. options
-
$388M
-
Value change
-
+$48.4M
-
Number of buys
-
47
-
Number of sells
-
-24
-
Price
-
$34.73
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q3 2019
86 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q3 2019.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.2M shares
of 29.1M outstanding shares and own 38.46% of the company stock.
Largest 10 shareholders include FMR LLC (1.15M shares), Redmile Group, LLC (1.08M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.08M shares), BAKER BROS. ADVISORS LP (1.03M shares), FRAZIER MANAGEMENT LLC (895K shares), BlackRock Inc. (752K shares), ORBIMED ADVISORS LLC (602K shares), VANGUARD GROUP INC (595K shares), CITADEL ADVISORS LLC (538K shares), and STATE STREET CORP (466K shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.